Stage III Ovarian Cancer: Jackie's Survivor Story

Patient Info: Jackie Page, Female, 50s | Stage III

In remission with no sign of recurrent disease at the September 2020 publication, while continuing treatment on the clinical trial.

Dana-FarberRead more →

Ovarian Cancer: Stacy's Patient Story

Patient Info: Stacy Saravo, female

After treatment, Stacy was active in survivorship, peer support, patient education, hiking, and scent-work activities with her dog.

Ovarian Wilms tumor with early abdominal recurrence

Patient Info: Anonymized, Female, Under 40

Biomarkers: WT1-positive; residual tumor MyoD1-positive

After 3 months of radiation and a further 3 months of chemotherapy, PET showed no FDG-avid malignancy.

PubMed CentralRead more →

Ovarian cancer that later spread to an axillary lymph node

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: axillary lymph nodes

After later peritoneal progression, additional treatment brought the disease to a stable state through her last recorded visit in July 2019.

PubMed CentralRead more →

Stage IV ovarian cancer with axillary lymph-node spread

Patient Info: Anonymized, Female, 50s | Stage IV

Metastatic Site: axillary lymph nodes

A 58-year-old woman with ovarian serous carcinoma and axillary lymph-node spread received chemotherapy, cytoreductive surgery, and postoperative chemotherapy.

PubMed CentralRead more →

Stage I Ovarian Cancer: Mary's Survivor Story

Patient Info: Mary “Dicey” Jackson Scroggins, 40s | Stage I

Nearly 2 decades after treatment, Dicey remained free of ovarian-cancer recurrence.

Stage III BRCA1 Ovarian Cancer: Patty's Patient Story

Patient Info: Patty Klein, Female | Stage III

Biomarkers: BRCA1 mutation

Patty was able to continue the olaparib plus BKM120 clinical trial as long as her tumor remained controlled. She later died.

Stage III Ovarian Cancer: Angela's Survivor Story

Patient Info: Angela Hernandez, female | Stage III

After completing chemotherapy, follow-up appointments continued to confirm that she was cancer-free.

MD AndersonRead more →

Employee, ovarian cancer survivor: Why I chose MD Anderson

Patient Info: Angela Hernandez, female, Under 40 | Stage III

She had been cancer-free since January 2019 after surgery and 4 rounds of carboplatin and etoposide.

MD AndersonRead more →

Stable Brain Metastases During Niraparib Maintenance for Ovarian Cancer

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Biomarkers: CA-125 4019 kU/L; pathogenic germline BRCA1 mutation

Metastatic Site: brain

After 17 months of niraparib, her brain metastases remained stable. She had a performance status of 0 and reported a full, normal quality of life.

PubMed CentralRead more →

Ovarian Cancer Relapse Causing Fluid Around the Heart

Patient Info: Anonymized, Female, 50s | Stage Metastatic/Advanced

Biomarkers: PAX8 positive; CK7 positive; WT1 positive; p53 positive; ER positive; PR negative; isolated PMS2 loss; MSH2 retained; MSH6 retained; MLH1 retained; two BRCA1 variants of uncertain significance

Metastatic Site: omentum|pericardium

She was alive after completing chemotherapy for the pericardial relapse and was receiving olaparib maintenance. The fluid around the heart did not recur immediately after the surgical window.

PubMed CentralRead more →

Small Cell Lung Cancer: Tabby's Survivor Story

Patient Info: Tabby Soignier, female, Under 40

A December 2011 CT scan and lab work showed Tabby was cancer-free; she continued regular follow-up and later conceived naturally and gave birth to a healthy son.

MD AndersonRead more →

Stage IV Ovarian Cancer With Severe Recurrent Ascites

Patient Info: Anonymized, Female | Stage IV

Metastatic Site: peritoneum|liver

The cancer progressed with massive ascites, liver involvement, and respiratory failure. She died from multiorgan failure related to metastatic ovarian cancer.

PubMed CentralRead more →

BRCA Ovarian Cancer: Dena's Patient Story

Patient Info: Dena Svoboda, Female, 50s

Biomarkers: BRCA mutation

Nearly 4 years after surgery and heated intraperitoneal chemotherapy, Dena’s cancer had not recurred, and she continued intravenous chemotherapy every 5 weeks with minimal side effects.

Cleveland ClinicRead more →

Advanced Ovarian Cancer Presenting With Dermatomyositis

Patient Info: Anonymized, Female, 50s

Biomarkers: CA-125 3169 at diagnosis; later CA-125 rise with progression

After a partial response to second-line chemotherapy, nodal disease progressed again 5 months later and liposomal doxorubicin was planned.

PubMed CentralRead more →

Ovarian Cancer With Pleural Spread and Recurrent Dermatomyositis

Patient Info: Anonymized, Female, 40s | Stage Metastatic/Advanced

Metastatic Site: pleura

She had symptomatic improvement after 2 cycles of carboplatin and liposomal doxorubicin for recurrent disease.

PubMed CentralRead more →

Recurrent Ovarian Cancer With Dermatomyositis and Peritoneal Progression

Patient Info: Anonymized, Female, 50s

Her disease progressed during weekly paclitaxel, and she was considered unfit for further treatment.

PubMed CentralRead more →

Stage IV Ovarian Cancer: Janelle's Patient Story

Patient Info: Janelle Kister, female | Stage IV

Treatment ended, and Janelle was still doing well 17 years after her Stage IV ovarian cancer diagnosis.

MD AndersonRead more →

Stage IV ovarian cancer presenting as a persistent umbilical ulcer

Patient Info: Anonymized, Female, 40s | Stage IV

Metastatic Site: bilateral cardiophrenic lymph nodes

She recovered from extensive cytoreductive surgery without major abdominal or pulmonary complications and began adjuvant paclitaxel and carboplatin on postoperative day 25.

PubMed CentralRead more →

Stage IV Ovarian Cancer With 20 Years of Tumor-Free Survival

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: BRCA1 negative, BRCA2 negative

Metastatic Site: peritoneum, liver, right adrenal gland

Regular follow-up found no recurrence or other tumor, and at 20 years of follow-up she remained tumor-free with good health and quality of life.

PubMed CentralRead more →

Ovarian Cancer: Leslie's Patient Story

Patient Info: Leslie Medley-Russell, female

She was receiving chemotherapy for a second ovarian cancer diagnosis while continuing to train and compete in endurance events.

MD AndersonRead more →

Ovarian Cancer: Leslie's Survivor Story

Patient Info: Leslie Medley-Russell, female

Biomarkers: CA-125 elevated at recurrence

After treatment for the January 2017 recurrence, she had no evidence of disease at the time of the story.

MD AndersonRead more →

Stage II BRCA1 Ovarian Cancer: Barb's Patient Story

Patient Info: Barb White, female, 50s | Stage II

Biomarkers: BRCA1 mutation

Barb completed chemotherapy in June 2014 and later described being able to move forward after treatment.

MD AndersonRead more →

Stage III Ovarian Cancer: Dianne's Patient Story

Patient Info: Dianne Simpson, female, 70+ | Stage III

Dianne completed treatment in April 2017 after chemotherapy, hysterectomy and a pembrolizumab clinical trial and was looking ahead to survivorship.

MD AndersonRead more →